Pharmaceutical giant Novo Nordisk, which produces Ozempic and Wegovy, currently dominates the market, though theyve faced supply shortages in recent months due to an increased demand
Phase 1 - Starting and Ramping Up (month 1 to 3) Dose: If one has had no prior GLP-1 therapy, they will be started on a very low dose of 0.25mg a week
A review in Aesthetic Surgery Journal confirming that calcium hydroxylapatite biostimulators produce progressive collagen induction over 12 months, making them superior to hyaluronic acid for patients with ongoing structural changes supports the clinical logic of using biostimulators early and adaptively in weight loss patients
Pregnancy considerations are important: Wegovy is contraindicated during pregnancy and should be discontinued at least 2 months before a planned pregnancy
Sattar N, Lee MMY, Kristensen SL, et al
The table below shows the expected mortality impact in our central scenario by market and by age